130 related articles for article (PubMed ID: 25547940)
1. Relation of body mass index to bleeding during percutaneous coronary interventions.
Ndrepepa G; Fusaro M; Cassese S; Guerra E; Schunkert H; Kastrati A
Am J Cardiol; 2015 Feb; 115(4):434-40. PubMed ID: 25547940
[TBL] [Abstract][Full Text] [Related]
2. Bleeding after percutaneous coronary intervention in women and men matched for age, body mass index, and type of antithrombotic therapy.
Ndrepepa G; Schulz S; Neumann FJ; Byrne RA; Hoppmann P; Cassese S; Ott I; Fusaro M; Ibrahim T; Tada T; Richardt G; Laugwitz KL; Schunkert H; Kastrati A
Am Heart J; 2013 Sep; 166(3):534-40. PubMed ID: 24016504
[TBL] [Abstract][Full Text] [Related]
3. Correlates of poor outcome among patients with bleeding after coronary interventions.
Ndrepepa G; Guerra E; Schulz S; Hoppmann P; Laugwitz KL; Kastrati A
Coron Artery Dis; 2014 Sep; 25(6):456-62. PubMed ID: 24801558
[TBL] [Abstract][Full Text] [Related]
4. Procedure-related bleeding in elective percutaneous coronary interventions.
Ndrepepa G; Stephan T; Fiedler KA; Guerra E; Kufner S; Kastrati A
Eur J Clin Invest; 2015 Mar; 45(3):263-73. PubMed ID: 25645583
[TBL] [Abstract][Full Text] [Related]
5. Prehospital statin therapy and one-year mortality in patients with stable coronary artery disease undergoing percutaneous coronary intervention.
Ndrepepa G; King L; Cassese S; Fusaro M; Tada T; Schömig A; Kastrati A
Eur J Intern Med; 2013 Mar; 24(2):145-50. PubMed ID: 23182629
[TBL] [Abstract][Full Text] [Related]
6. Impact of body mass index on clinical outcome in patients with acute coronary syndromes treated with percutaneous coronary intervention.
Ndrepepa G; Keta D; Byrne RA; Schulz S; Mehilli J; Seyfarth M; Schömig A; Kastrati A
Heart Vessels; 2010 Jan; 25(1):27-34. PubMed ID: 20091395
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.
Lindsey JB; Marso SP; Pencina M; Stolker JM; Kennedy KF; Rihal C; Barsness G; Piana RN; Goldberg SL; Cutlip DE; Kleiman NS; Cohen DJ;
JACC Cardiovasc Interv; 2009 Nov; 2(11):1074-82. PubMed ID: 19926047
[TBL] [Abstract][Full Text] [Related]
8. Body mass index, periprocedural bleeding, and outcome following percutaneous coronary intervention (from the British Columbia Cardiac Registry).
Byrne J; Spence MS; Fretz E; Mildenberger R; Chase A; Berry B; Pi D; Janssen C; Klinke P; Hilton D
Am J Cardiol; 2009 Feb; 103(4):507-11. PubMed ID: 19195511
[TBL] [Abstract][Full Text] [Related]
9. Increased bleeding risk during percutaneous coronary interventions by arterial hypertension.
Ndrepepa G; Groha P; Lahmann AL; Lohaus R; Cassese S; Schulz-Schüpke S; Kufner S; Mayer K; Bernlochner I; Byrne RA; Fusaro M; Laugwitz KL; Schunkert H; Kastrati A
Catheter Cardiovasc Interv; 2016 Aug; 88(2):184-90. PubMed ID: 26526702
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs).
Cuisset T; Grosdidier C; Loundou AD; Quilici J; Loosveld M; Camoin L; Pankert M; Beguin S; Lambert M; Morange PE; Bonnet JL; Alessi MC
JACC Cardiovasc Interv; 2013 Aug; 6(8):854-63. PubMed ID: 23968703
[TBL] [Abstract][Full Text] [Related]
11. The predictive value of plasma cystatin C for acute coronary syndrome treated with percutaneous coronary intervention.
Sun TW; Xu QY; Yao HM; Zhang XJ; Wu Q; Zhang JY; Li L; Zhang YZ; Kan QC; Guan FX; Wang LX
Heart Lung; 2012; 41(5):456-62. PubMed ID: 22652172
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of the SYNTAX score to predict acute kidney injury after percutaneous coronary intervention (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial).
Madhavan MV; Généreux P; Rubin J; Palmerini T; Caixeta A; Xu K; Weisz G; Mehran R; Stone GW
Am J Cardiol; 2014 Apr; 113(8):1331-7. PubMed ID: 24560063
[TBL] [Abstract][Full Text] [Related]
13. Differences in sex-related bleeding and outcomes after percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) registry.
Othman H; Khambatta S; Seth M; Lalonde TA; Rosman HS; Gurm HS; Mehta RH
Am Heart J; 2014 Oct; 168(4):552-9. PubMed ID: 25262266
[TBL] [Abstract][Full Text] [Related]
14. Interventional cardiology: BMI inversely associated with bleeding and mortality after PCI.
Geach T
Nat Rev Cardiol; 2015 Feb; 12(2):65. PubMed ID: 25511083
[No Abstract] [Full Text] [Related]
15. Comparison of adverse outcomes after contemporary percutaneous coronary intervention in women versus men with acute coronary syndrome.
Pendyala LK; Torguson R; Loh JP; Kitabata H; Minha S; Badr S; Dvir D; Barbash IM; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2013 Apr; 111(8):1092-8. PubMed ID: 23352262
[TBL] [Abstract][Full Text] [Related]
16. Impact of inhospital stent thrombosis and cerebrovascular accidents on long-term prognosis after percutaneous coronary intervention.
Guerra E; Ndrepepa G; Schulz S; Byrne R; Hoppmann P; Kufner S; Ibrahim T; Tada T; Schunkert H; Laugwitz KL; Kastrati A
Am Heart J; 2014 Dec; 168(6):862-8.e1. PubMed ID: 25458649
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of access and non-access sites bleeding after percutaneous coronary intervention.
Ndrepepa G; Neumann FJ; Richardt G; Schulz S; Tölg R; Stoyanov KM; Gick M; Ibrahim T; Fiedler KA; Berger PB; Laugwitz KL; Kastrati A
Circ Cardiovasc Interv; 2013 Aug; 6(4):354-61. PubMed ID: 23881814
[TBL] [Abstract][Full Text] [Related]
18. Sex Differences in Radial Access for Percutaneous Coronary Intervention in Acute Coronary Syndrome Are Independent of Body Size.
Stehli J; Duffy SJ; Koh Y; Martin C; Brennan A; Dinh DT; Lefkovits J; Zaman S
Heart Lung Circ; 2021 Jan; 30(1):108-114. PubMed ID: 32855068
[TBL] [Abstract][Full Text] [Related]
19. Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).
Whellan DJ; Tricoci P; Chen E; Huang Z; Leibowitz D; Vranckx P; Marhefka GD; Held C; Nicolau JC; Storey RF; Ruzyllo W; Huber K; Sinnaeve P; Weiss AT; Dery JP; Moliterno DJ; Van de Werf F; Aylward PE; White HD; Armstrong PW; Wallentin L; Strony J; Harrington RA; Mahaffey KW
J Am Coll Cardiol; 2014 Mar; 63(11):1048-57. PubMed ID: 24211500
[TBL] [Abstract][Full Text] [Related]
20. Optimizing P2Y12 receptor inhibition in patients with acute coronary syndrome on the basis of platelet function testing: impact of prasugrel and high-dose clopidogrel.
Aradi D; Tornyos A; Pintér T; Vorobcsuk A; Kónyi A; Faluközy J; Veress G; Magyari B; Horváth IG; Komócsi A
J Am Coll Cardiol; 2014 Mar; 63(11):1061-70. PubMed ID: 24486281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
